Gadolinium-induced nephrotoxicity

International Journal of Clinical Practice

Volumn 62, Issue 7, 2008, Pages 1113-1118

  Buhaescu, I ^a   Izzedine, H ^b  

^a SAINT VINCENT HOSPITAL   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; GADOBUTROL; GADODIAMIDE; GADOLINIUM; GADOLINIUM CHELATE; GADOLINIUM CHLORIDE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERIDOL; GADOVERSETAMIDE; IODINATED CONTRAST MEDIUM; IOHEXOL;

ABSENCE OF SIDE EFFECTS; ACUTE KIDNEY FAILURE; ANAPHYLAXIS; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CONTRAST MEDIUM INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG MEGADOSE; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; HYPEROSMOLARITY; INTERVENTIONAL RADIOLOGY; KIDNEY ARTERIOGRAPHY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; NAUSEA; NEPHROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; RENOVASCULAR DISEASE; REVIEW; RISK FACTOR; SIDE EFFECT; URTICARIA;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; GLOMERULAR FILTRATION RATE; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; RENAL INSUFFICIENCY, ACUTE; RENAL INSUFFICIENCY, CHRONIC;

EID: 44849104294     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01582.x     Document Type: Review

References (44)

1. Solomon R. Contrast-medium-induced acute renal failure. Kidney Int 1998 53 : 230 42.
2. Pannu N, Wiebe N, Tonelli M. Alberta kidney disease network. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006 295 : 2765 79.
3. Porter GA. Contrast associated nephropathy. Am J Cardiol 1989 64 : 22E 6E.
4. Fenves AZ, Allgren RL. Radio contrast dye-induced acute tubular necrosis (ATN): atrial natriuretic peptide (ANP) vs placebo (abstr). Am Soc Nephrol 1995 6 : 463.
5. Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 2001 56 : 935 41.
6. Levey EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996 275 : 1489 94.
7. Runge BM. Safety of approved MRI contrast media for intravenous injection. Magn Reson Imaging 2000 12 : 205 13.
8. Cacheris WP, Quay SC, Rocklage SM. The relationship between thermodynamics and the toxicity of gadolinium complexes. Magn Reson Imaging 1990 8 : 467 81.
9. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999 10 : 477 84.
10. Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media -gadolinium chelates. Br J Radiol 2006 79 : 368 71.
11. Beaudouin E, Kanny G, Blanloeil Y, Guilloux L, Renaudin JM, Moneret-Vautrin DA. Anaphylactic shock induced by gadoterate meglumine (DOTAREM). Allerg Immunol (Paris) 2003 35 : 382 5.
12. Grobner T, Prischl FC. Gadolinium and nephrogenic systemic fibrosis. Kidney Int 2007 72 : 260 4.
13. Arsenault TM, King BF, Marsh JW et al. Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc 1996 71 : 1150 4.
14. Zhang HL, Ersoy H, Prince MR. Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements. J Magn Reson Imaging 2006 23 : 383 7.
15. Rieger J, Sitter T, Toepfer M, Linsenmeier U, Pfeifer KJ, Schiffl H. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 2002 17 : 824 8.
16. Tombach B, Bremer C, Reimer P et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology 2001 218 : 651 7.
17. Hoffmann U, Fischereder M, Reil A, Fischer M, Link J, Kramer BK. Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function. Eur J Med Res 2005 10 : 149 54.
18. Ailawadi G, Stanley JC, Williams DM, Dimick JB, Henke PK, Upchurch GR Jr. Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg 2003 37 : 346 52.
19. Hammer FD, Malaise J, Goffette PP, Mathurin P. Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography in patients with renal failure. Transplant Proc 2000 32 : 432 3.
20. Wagner HJ, Kalinowski M, Klose KJ, Alfke H. The use of gadolinium chelates for x-ray digital subtraction angiography. Invest Radiol 2001 36 : 257 65.
21. Sancak T, Bilgic S, Sanlidilek U. Gadodiamide as an alternative contrast agent in intravenous digital subtraction angiography and interventional procedures of the upper extremity veins. Cardiovasc Intervent Radiol 2002 25 : 49 52.
22. Haustein J, Niendorf HP, Krestin G et al. Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 1992 27 : 153 6.
23. Heinrich MC, Kuhlmann MK, Kohlbacher S et al. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Radiology 2007 242 : 425 34.
24. Elmstahl B, Nyman U, Leander P, Chai CM, Frennby B, Almen T. Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs. Acad Radiol 2004 11 : 1219 28.
25. Sekido T, Sagami F, Tirone P, Morisetti A, Bussi S, Masters RE. General toxicity study of gadobenate dimeglumine formulation (E7155) (2): single dose intravenous toxicity study in dogs [abstract]. J Toxicol Sci 1999 24 : 7 18.
26. Spencer A, Wilson S, Harpur E. Gadolinium chloride toxicity in the mouse. Hum Exp Toxicol 1998 17 : 633 7.
27. Sam AD II., Morasch MD, Collins J et al. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 2003 38 : 313 18.
28. Ergun I, Keven K, Uruc I et al. The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant 2006 21 : 697 700.
29. Nyman U, Elmstahl B, Leander P et al. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia Radiology 2002 223 : 311 8.
30. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994 5 : 125 37.
31. Berns AS. Nephrotoxicity of contrast media. Kidney Int 1989 36 : 730 7.
32. Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003 76 : 513 8.
33. Nikolsky E, Mehran R, Lazic Z et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005 67 : 706 13.
34. Erley CM, Bader BD, Berger ED. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant 2004 19 : 2526 31.
35. Briguori C, Colombo A, Airoldi F et al. Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures. Catheter Cardiovasc Interv 2006 67 : 175 80.
36. Thomsen HS. Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 2004 14 : 1654 6.
37. Schenker MP, Solomon JA, Roberts DA. Gadolinium arteriography complicated by acute pancreatitis and acute renal failure. J Vasc Interv Radiol 2001 12 : 393.
38. Gemery J, Idelson B, Reid S et al. Acute renal failure after arteriography with a gadolinium-based contrast agent. Am J Roentgenol 1998 171 : 1277 8.
39. Haustein J, Niendorf HP, Krestin G et al. Renal tolerance of gadolinium DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 1992 27 : 153 6.
40. Persson PB, Patzak A. Renal haemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration. Nephrol Dial Transplant 2005 20 (Suppl. 1 i2 5.
41. Tumlin J, Stacul F, Adam A et al. CIN Consensus Working Panel. Pathophysiology of contrast-induced nephropathy. Am J Cardiol 2006 98 : 14K 20K.
42. Murphy SW, Barrett BJ, Parfre PS. Contrast nephropathy. J Am Soc Nephrol 2000 11 : 177 82.
43. Thomsen HS, Morcos SK. Radiographic contrast media. BJU Int 2000 86 (Suppl. 1 1 10.
44. Akgun H, Gonlusen G, Cartwright J Jr., Suki WN, Truong LD. Are gadolinium-based contrast media nephrotoxic? A renal biopsy study. Arch Pathol Lab Med 2006 130 : 1354 7.